Kalexo Bio
PrivateLast Round
Corporate Funding
Sep 17, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kalexo Bio is a drug discovery company that develops siRNA-based therapeutics for the treatment of cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kalexo Bio Comparables
Compare Kalexo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sirius Therapeutics, Inc. | 86% | |
| Rona Therapeutics | 84% | |
| Suzhou Siran Biotechnology Co., Ltd. | 77% |
Kalexo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Sep 17, 2025 |
Kalexo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aditum Bio | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2025
Led by Aditum Bio with participation from Mabwell.
Kalexo Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kalexo Bio's valuation, stock price, and market status.
Is Kalexo Bio a public or private company?
Kalexo Bio is a private company.
What is the current stock price of Kalexo Bio?
Kalexo Bio is a private company with no public stock price. Caplight tracks Kalexo Bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Kalexo Bio worth (valuation)?
Valuation information for Kalexo Bio is not publicly available.
Can I buy Kalexo Bio stock?
Kalexo Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kalexo Bio's last funding round?
Kalexo Bio's most recent funding round was Corporate Funding on September 17, 2025.
Who are the main investors in Kalexo Bio?
Key investors in Kalexo Bio include Aditum Bio.
Will Kalexo Bio IPO soon?
No public IPO plans have been announced for Kalexo Bio.
How can I track Kalexo Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kalexo Bio's secondary market activity and sign up for updates.